Cormedix Financial Overview
Cormedix's market cap is currently $901.35M. The company's EPS TTM is $1.26; its P/E ratio is 5.58; Cormedix is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $0.84. See an overview of income statement, balance sheet, and cash flow financials.
